Spirovant
  • Home
  • Science
    • Technology
    • Pipeline
  • About Us
  • Newsroom
    • Press Releases
    • Publications
  • Careers
  • Contact Us
Menu
  • Home
  • Science
    • Technology
    • Pipeline
  • About Us
  • Newsroom
    • Press Releases
    • Publications
  • Careers
  • Contact Us

Category: Publications

<a href="https://pubmed.ncbi.nlm.nih.gov/15564131/">Dual therapeutic utility of proteasome modulating agents for pharmaco-gene therapy of the cystic fibrosis airway</a>

<a href="https://pubmed.ncbi.nlm.nih.gov/14990705/">Distinct classes of proteasome-modulating agents cooperatively augment recombinant adeno-associated virus type 2 and type 5-mediated transduction from the apical surfaces of human airway epithelia</a>

<a href="https://pubmed.ncbi.nlm.nih.gov/11854474/">CFTR with a partially deleted R domain corrects the cystic fibrosis chloride transport defect in human airway epithelia in vitro and in mouse nasal mucosa in vivo</a>

newer →

Spirovant Sciences, Inc.
3675 Market Street, Suite 900 Philadelphia, PA 19104
info@spirovant.com
(267) 244-8206

Twitter Linkedin
  • Terms of Use
  • Privacy Policy
Menu
  • Terms of Use
  • Privacy Policy

© Copyright 2016-2024 Spirovant Sciences Inc. All rights reserved.